Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients
Clinical trial NCT04684381 · COMPLETED
Trial details
- NCT number
- NCT04684381
- Sponsor
- Emmaus Medical, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2021-06-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.